Literature DB >> 31332049

Should national pharmacare apply a value-based insurance design?

Kai Yeung1, Steven G Morgan2.   

Abstract

Mesh:

Substances:

Year:  2019        PMID: 31332049      PMCID: PMC6645923          DOI: 10.1503/cmaj.181721

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  30 in total

1.  Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment.

Authors:  Paul Grootendorst
Journal:  Can J Clin Pharmacol       Date:  2002

Review 2.  Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.

Authors:  Joel Lexchin; Paul Grootendorst
Journal:  Int J Health Serv       Date:  2004       Impact factor: 1.663

3.  Reducing patient drug acquisition costs can lower diabetes health claims.

Authors:  John J Mahoney
Journal:  Am J Manag Care       Date:  2005-08       Impact factor: 2.229

4.  Impact of decreasing copayments on medication adherence within a disease management environment.

Authors:  Michael E Chernew; Mayur R Shah; Arnold Wegh; Stephen N Rosenberg; Iver A Juster; Allison B Rosen; Michael C Sokol; Kristina Yu-Isenberg; A Mark Fendrick
Journal:  Health Aff (Millwood)       Date:  2008 Jan-Feb       Impact factor: 6.301

5.  Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries.

Authors:  Jae Kennedy; Steve Morgan
Journal:  Clin Ther       Date:  2009-01       Impact factor: 3.393

6.  Evidence that value-based insurance can be effective.

Authors:  Michael E Chernew; Iver A Juster; Mayur Shah; Arnold Wegh; Stephen Rosenberg; Allison B Rosen; Michael C Sokol; Kristina Yu-Isenberg; A Mark Fendrick
Journal:  Health Aff (Millwood)       Date:  2010-01-21       Impact factor: 6.301

7.  Unintended consequences of caps on Medicare drug benefits.

Authors:  John Hsu; Mary Price; Jie Huang; Richard Brand; Vicki Fung; Rita Hui; Bruce Fireman; Joseph P Newhouse; Joseph V Selby
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

8.  Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis.

Authors:  Michele Heisler; Hwajung Choi; Allison B Rosen; Sandeep Vijan; Mohammed Kabeto; Kenneth M Langa; John D Piette
Journal:  Med Care       Date:  2010-02       Impact factor: 2.983

9.  Pharmacy benefits and the use of drugs by the chronically ill.

Authors:  Dana P Goldman; Geoffrey F Joyce; Jose J Escarce; Jennifer E Pace; Matthew D Solomon; Marianne Laouri; Pamela B Landsman; Steven M Teutsch
Journal:  JAMA       Date:  2004-05-19       Impact factor: 56.272

Review 10.  Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

Authors:  Dana P Goldman; Geoffrey F Joyce; Yuhui Zheng
Journal:  JAMA       Date:  2007-07-04       Impact factor: 56.272

View more
  2 in total

1.  Who assigns value in value-based insurance design?

Authors:  Joel Lexchin
Journal:  CMAJ       Date:  2020-01-06       Impact factor: 8.262

Review 2.  A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.

Authors:  G Emmanuel Guindon; Tooba Fatima; Sophiya Garasia; Kimia Khoee
Journal:  BMC Health Serv Res       Date:  2022-03-03       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.